Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Metastatic Colorectal Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Colorectal Cancer Trial

NCT03149679 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT03149679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03149679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Metastatic Colorectal Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Colorectal Cancer Trial
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
May 9, 2017
Completion date
August 7, 2020
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, colorectal cancer stage iv, tp53 gene mutation